High Tower Advisors, LLC Amarin Corp Plcuk Transaction History
High Tower Advisors, LLC
- $64.2 Billion
- Q2 2024
A detailed history of High Tower Advisors, LLC transactions in Amarin Corp Plcuk stock. As of the latest transaction made, High Tower Advisors, LLC holds 121,391 shares of AMRN stock, worth $74,048. This represents 0.0% of its overall portfolio holdings.
Number of Shares
121,391
Previous 102,691
18.21%
Holding current value
$74,048
Previous $91,000
8.79%
% of portfolio
0.0%
Previous 0.0%
Shares
24 transactions
Others Institutions Holding AMRN
# of Institutions
187Shares Held
77.1MCall Options Held
247KPut Options Held
121K-
Sarissa Capital Management LP Greenwich, CT24.9MShares$15.2 Million2.89% of portfolio
-
Kynam Capital Management, LP Princeton, NJ12.2MShares$7.42 Million0.65% of portfolio
-
Dg Capital Management, LLC New York, NY5.12MShares$3.12 Million1.36% of portfolio
-
Eversept Partners, LP New York, NY4.31MShares$2.63 Million0.22% of portfolio
-
Two Sigma Investments, LP New York, NY3.04MShares$1.85 Million0.01% of portfolio
About AMARIN CORP PLCUK
- Ticker AMRN
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 403,206,016
- Market Cap $246M
- Description
- Amarin Corporation plc, a pharmaceutical company, engages in the development and commercialization of therapeutics for the treatment of cardiovascular diseases in the United States, Germany, Canada, Lebanon, and the United Arab Emirates. Its lead product is VASCEPA, a prescription-only omega-3 fatty acid product, used as an adjunct to diet for r...